Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

606P - Molecular characterization of non-tobacco related lung adenocarcinoma: A multi-omics study in South-East China

Date

07 Dec 2024

Session

Poster Display session

Presenters

Jinman Zhuang

Citation

Annals of Oncology (2024) 35 (suppl_4): S1616-S1622. 10.1016/annonc/annonc1696

Authors

J. Zhuang, F. He

Author affiliations

  • Department Of Epidemiology And Health Statistics, School Of Public Health, Fujian Medical University - Qishan Campus, 350122 - Fuzhou/CN

Resources

This content is available to ESMO members and event participants.

Abstract 606P

Background

The incidence of non-tobacco related (non-smoker without second-hand smoke exposure) lung cancer remains a global health problem, thorough knowledge about the molecular features is still lacking. Our aim was to constructed a comprehensive multi-omics profiling that can enlighten the etiology and unique omics features of non-tobacco related lung adenocarcinoma (NTR-LUAD).

Methods

We performed comprehensive genomic, transcriptomic, proteomic, and metabolomic analysis in 87 pairs of tumor and normal tissue in NTR-LUAD patients. We detect the significantly mutated genes (SMGs) and copy number variation (CNV) by mutation significance with covariates (MutsigCV) and GISTIC2.0 software. We also collected the clinical and pathological features to integrate multi-omics analysis. The differential expression about genes and proteins between different groups were identified by limma package. We used argparser to run different metabolin analysis.

Results

At gene level, after excluding the effects of gene length and background mutation rate, we identified 43 SMGs (P<0.005), top gene was EGFR (68%). Mutational signature analysis results showed that the signature aging-related mutational signature was most enrich in NTR-LUAD. A total of 5026 differentially expressed genes (logFC>1 or logFC<-1, P adjust<0.05), 2626 differentially expressed protein (logFC>1 or logFC<-1, P adjust<0.05) and 199 differential metabolites (FC>2 or FC<0.5, VIP>1, P<0.05) were found in differentially analysis between cancer and paracancer tissues. We compared gene expression level and protein expression level between different stages and found that genes and proteins varied with stage were all enriched in cytoskeleton in muscle cells, ECM-receptor interaction, protein digestion and absorption and focal adhesion (P adjust<0.05). All differentially metabolites were enrich in purine metabolism (FDR=0.007).

Conclusions

This multi-omic molecular architecture may help develop strategies for management of NTR-LUAD.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Fujian Province science and technology innovation joint fund project (2019Y9022).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.